Prunolactones A-G, proangiogenic isocoumarin derivatives with an unusual 6/6/6/6/6 spiropentacyclic skeleton from the endophytic fungus Phomopsis prunorum.

Seven novel isocoumarins, prunolactones A-G (1-7), featuring an unusual 6/6/6/6/6 spiropentacyclic skeleton, together with two biosynthetic precursors phomopsilactone (8) and methyl 3-epi-shikimate (9), were isolated from the endophytic fungus Phomopsis prunorum guided by UPLC-QTOF-MS and 1H NMR spectroscopic analytical techniques. Their structures including absolute configurations of 1-7 were elucidated based on extensive spectroscopic data, X-ray diffraction analysis, and ECD calculations. Biogenetically, compounds 1-7 are proposed to be derived from polyketide and shikimate pathways via key intermolecular Diels - Alder reactions. Compounds 2, 3, and 7 showed significant in vivo proangiogenic activity in transgenic zebrafish.

Elevated homocysteine and hypertension in Xinjiang Province, China.

BACKGROUND: Few data are available comparing homocysteine (Hcy) levels in patients with hypertension in different ethnic groups. OBJECTIVES: This study sought to determine whether there are associations of blood pressure and Hcy levels in patients with hypertension from Xinjiang Province, China. METHODS: We examined the serum total Hcy levels in a total of 451 Chinese of various ethnic groups (Han n=234 [51.9%], Uygur n=102 [22.6%], Kazak n=61 [13.5%], Hui n=54 [12.0%]) aged 18-78 years. Two groups of subjects were studied: 1) non-hypertensive, n=101; (2) hypertensive, n=350. We investigated the serum Hcy levels relationship with hypertension. RESULTS: Hcy levels of Kazak in no hypertension and hypertension patients were highest (11.9 +/- 9.8 vs 19.0 +/- 11.8 umol/L, respectively, unadjusted P=.004, adjusted P=.016). This pattern of higher Hcy values in hypertension patients was consistent across all ethnic groups even after adjustment (all P<0.05). The hypertension risks in the elevated Hcy (>13.9 umol/L) was 3.5 (95% CI, 2.2-5.4) times the normal Hcy (< or = 13.9 umol/L) (P<0.001). Even after adjustment for potential confounders, this difference remained 3.1 times higher (95% CI, 1.9-4.8) (P<.001). Bivariate correlation analysis revealed a statistically significant relationship of Hcy with systolic or diastolic blood pressure across all ethnic groups. CONCLUSION: This study confirms the existence of a significant association between hypertension and Hcy in Chinese population groups.

Association between hyperuricemia and hypertension in a Chinese population at a high risk of hypertension.

In this cross-sectional study, we examined whether hyperuricemia is associated with hypertension and the association exists in a Chinese population at a high risk of hypertension. The study population included 813 consecutively clinical patients with suspected cardiovascular disease, including the subjects with the current use of antihypertensive medications and self-reported diagnosis of hypertension. The subjects underwent three measures of blood pressure and were divided into two groups: 502 non-hypertensive subjects and 311 hypertensive subjects. Clinical and biochemical variables were measured. Results showed that uric acid level, fasting glucose, low-density lipoprotein (LDL)-cholesterol, total cholesterol and urea nitrogen were significantly higher (all p<0.05) in hypertension subjects than in non-hypertension subjects. The risk of hypertension was significantly higher in the group with higher uric acid (>400 micromol/l), compared with that with lower uric acid (<200 micromol/l) (odds ratio: 2.09, 95% CI 1.13-3.88). The odds ratio was 1.73, 95% CI 1.05-2.85 in the higher uric acid (200-400 micromol/l) group, compared with that with lower uric acid. In addition, age, gender, weight, fasting glucose, triglycerides and total cholesterol were also significantly associated with the incidence of hypertension. In age-adjusted logistic regression analysis, the effect of uric acid concentration on hypertension was attenuated. In conclusion, hyperuricemia is associated with hypertension in a Chinese population at a high risk of hypertension.